Catalyst Wire Dossier Catalyst Wire Dossier

Doxylamine succinate and pyridoxine hydrochloride, delayed-release tablets

Doxylamine succinate and pyridoxine hydrochloride · Endo USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Doxylamine succinate and pyridoxine hydrochloride, delayed-release tablets, covering 2020-02-24 to 2020-02-24. Get the full timeline:

Most recent: FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)

See pricing